C
CYP
CYNATA THERAPEUTICS
0.21
-0.01-2.33%Opening12:55 01/22 AEDT
OPEN/PREV CLOSE0.220/0.215
TODAY RANGE0.210-0.220
VOL204.36K
MARKET CAP47.30M
52 WEEK RANGE0.105-0.345
AVG VOL (3M)294.69K
% TURNOVER0.09%
TURNOVER43.53K
P/E (TTM)-3.8745
% RANGE4.65%
EPS(TTM)-0.0542
P/E(FORWARD)-4.5652
P/B5.22
BVPS0.040
DIVIDEND--
P/S91.30
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP41.24M
SHARES OUTSTANDING225.25M
NEXT EARNINGS02/20-02/24
FREE FLOAT196.37M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
ASX·1d ago
Results of Meeting
ASX·01/12 22:28
Cynata to Present at Biotech Showcase
ASX·12/31/2024 02:38
Change in substantial holding - Phillip Asset Management
ASX·12/20/2024 01:46
Letter to Shareholders, Notice of EGM&Proxy Form
Dow Jones·12/16/2024 02:28
*Cynata Therapeutics Target Price Cut 11% to A$0.67/Share by Euroz Hartleys>CYP.AU
ASX·12/15/2024 22:28
Cleansing Notice
ASX·12/15/2024 22:24
Application for quotation of securities - CYP
ASX·12/11/2024 21:53
First Kidney Transplant Trial Patient Treated
ASX·12/09/2024 21:53
Investor Webinar
ASX·12/05/2024 22:39
Proposed issue of securities - CYP
ASX·12/05/2024 22:39
Cynata secures commitments for $8.1m institutional placement
PR Newswire·12/05/2024 03:34
CYP-006TK Demonstrates Safety and Efficacy in DFU Clinical Trial
ASX·12/04/2024 23:43
Demonstrated Safety&Efficacy in DFU Clinical Trial
ASX·12/03/2024 21:45
Trading Halt
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others